TENUATE Drug Patent Profile
✉ Email this page to a colleague
When do Tenuate patents expire, and what generic alternatives are available?
Tenuate is a drug marketed by Sanofi Aventis Us and Nostrum Labs Inc and is included in four NDAs.
The generic ingredient in TENUATE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenuate
A generic version of TENUATE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
Summary for TENUATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Patent Applications: | 643 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TENUATE at DailyMed |
US Patents and Regulatory Information for TENUATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TENUATE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017669-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nostrum Labs Inc | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nostrum Labs Inc | TENUATE | diethylpropion hydrochloride | TABLET;ORAL | 011722-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | TENUATE | diethylpropion hydrochloride | TABLET;ORAL | 017668-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |